Thought Leadership

Driving Digital Excellence: Delivering Seamless and Personalized Customer-Centric Experiences

The digital evolution in reaching and engaging with global communities, including sponsors, CROs, patients, and HCPs, has drastically shifted the way medical affairs teams connect with key stakeholders. As the industry pursues ways to improve a consumer and patient-centric...

Intellectual Property (IP) Strategies to Consider for Life Sciences Start-Ups

Intellectual property (IP) is one of the most valuable assets a life sciences innovator or start-up has. While these companies are often built on the foundations of successful pre-clinical studies, they face a substantial amount of time between obtaining regulatory approvals and...

Clinical Data Services Company Launches its Statistical Webinar Series

“Another great seminar in a long line of excellence. I can only say, keep it up!”...

Electronic Product Information – Everything You Need to Know

One of the latest initiatives being spearheaded by EMA is publishing ePI, or electronic product information. In some respects, the pharma industry has lagged behind other major industries in terms of how documentation and critical information is relayed to the end patient. Due to...

Global Pharma Saves $1.1M with Regulatory Translation Solution

AI-powered workflows to help reduce costs and timelines while being scalable to the large volume of content required....

Pharma Digital Marketing: Trends for Customer Engagement

Trends for Pharma Digital Marketing All you need to know about above-the-line and below-the-line advertising and multichannel and omnichannel engagementIn today’s evolving digital landscape, companies are looking for the best ways to improve customer experience and...

Why Automate the Literature Monitoring Process?

A key concern for pharma companies is keeping a close eye on publications that might mention their product and its potential impact on the public. These publications can be extremely dense in volume, commanding careful review of multiple documents across several different sources...

Leveraging the Patent Priority Date: A Life Sciences Focus

The ACC last month hosted the San Francisco Bay Area Life Sciences CLE Conference, giving TransPerfect Legal Solutions (TLS) team members the opportunity to learn and connect with colleagues. One of the panels, moderated by Alex Trimble, Partner at Mintz Levin, Cohn, Ferris,...

Content Automation to Meet MDR & IVDR Requirements

Marc Miller, President of TransPerfect's Medical Device Solutions chatted with experts from Takeda Pharmaceuticals & QServe to learn about MDR & IVDR labeling compliance while cutting risk, cost, & turnaround by using structured content, process automation, &...

Digital Health’s Role in Improving Patient Engagement

​ In recent years, the patient journey has become more virtual, with patients seeking online information prior to engaging with healthcare providers (HCPs). Even as we transition back into traditional, in-person patient care, digital health is proving to be much more than just a...

4 Ways a CCMS Can Help Medical Affairs Achieve Global Content Reuse and Omnichannel Delivery

The medical affairs industry is undergoing a widespread digital transformation in the new era of patient centricity. Pharma companies must adapt their delivery of important medical information, such as patient outcomes, to effectively reach relevant stakeholders if they want to...

Leveraging Artificial Intelligence (AI) in Pharmacovigilance

Expert-driven technologies are continually being implemented into the clinical process to eliminate manual burdens and ramp up efficiencies. AI-enabled automated systems help to remove the barriers that prevent high-quality data and compliance in reporting of clinical events....

The Evolving Machine Translation and Translation Memory Landscape for Life Sciences

Over the past 70+ years and to this day, translation technology has changed drastically as more companies are focusing on ways to improve their tech performance with data that is higher quality and customizable. Consequently, life sciences organizations have been...

Novo Nordisk Delivers Multilingual Digital Experiences Through GlobalLink and Adobe

"Before GlobalLink for AEM we had to manage translation processes outside AEM, adding an extra layer of processes and approval flows into our work stream. Now it all happens within the same system, making translation and approvals flows smoother."...

Sanofi - The Clinical Translation Centralization Journey in Light of the EUCTR 536/2014

Sanofi centralizes clinical trial translations through GlobalLink and best-in-class AI, MT, and more. ...

Pfizer - Unlocking the Power of GlobalLink Within Pfizer Medical Information

GlobalLink and AI enable faster, better decisions in response to patient queries. ...

Rapidly Bringing HCP Support Tools to Global Markets at Scale

GlobalLinks helps AstraZeneca launch HCP tools around the world. ...

A Comparison Between Document Management Systems (DMS) and Component Content Management Systems (CCMS) for Pharma

CHOOSING THE RIGHT OPTION FOR YOU AND YOUR BUSINESS NEEDS Global pharma companies produce and manage a lot of content that is complexly intertwined. To mitigate risk, ensure patient safety, meet regulatory compliance standards, and reduce cycle times for faster drug-to...

Your Treatment Plan for Curing the App Localization Headache

If translation had a prefrontal cortex, in-country review would create quite the headache.  This is particularly true for app localization. App localization is the process of adapting apps and their content to another language in a conceptually equivalent and culturally...

An Unlikely Perfect Pairing: Life Sciences & Translation

What Is Life Sciences Translation? Let’s first define the term “translation” within a life sciences context. Life sciences translation is the adaptation of clinical documentation and MedTech materials across different languages. While the concept may seem relatively simple, it...

The Importance of Over-the-Phone Interpretation for Emergency Services

Imagine calling 911 in a state of crisis at the scene of an emergency situation, only to hear the call handler trying to understand you. And there’s nothing wrong with the connection—the poor communication is only because the person doesn’t speak your language.This kind of...

Let’s Chat About Chatbots: Part 1

According to Valuates Reports, the conversational AI market is projected to reach $32.62 billion by 2030, up from $5.78 billion in 2020. While it is clear chatbots and their uses are growing, it’s important to understand what a chatbot is exactly, its uses and benefits, and...

Let’s Chat About Chatbots: Part 2

In our last post, we discussed how business are deploying and benefiting from chatbots. Now that you have a basic understanding of what chatbots are and how they work, the next step is implementing them into your business model. For life sciences companies that are unsure of...

Digital Health Tools and Patient Support in China

Digital health has been a trending topic in the life sciences space, and has gained particular momentum due to the COVID-19 outbreak. In 2020, the global digital health market was valued at over $141.8 billion. This is expected to increase in value at a compound annual...